Colocation of the genes encoding ABC, TRAP, and TCT transport systems and catabolic pathways for the transported ligand provides a strategy for discovering novel microbial enzymes and pathways. We screened solute-binding proteins (SBPs) for ABC transport systems and identified three that bind d-apiose, a branched pentose in the cell walls of higher plants. Guided by sequence similarity networks (SSNs) and genome neighborhood networks (GNNs), the identities of the SBPs enabled the discovery of four catabolic pathways for d-apiose with eleven previously unknown reactions. The new enzymes include d-apionate oxidoisomerase, which catalyzes hydroxymethyl group migration, as well as 3-oxo-isoapionate-4-phosphate decarboxylase and 3-oxo-isoapionate-4-phosphate transcarboxylase/hydrolase, which are RuBisCO-like proteins (RLPs). The web tools for generating SSNs and GNNs are publicly accessible (http://efi.igb.illinois.edu/efi-est/), so similar 'genomic enzymology' strategies for discovering novel pathways can be used by the community.
T he UniProt database (http://www.uniprot.org/; 99,261,416 entries in release 2017_11; increasing with a doubling time of ~2.5 years) is partitioned between proteins that have functional annotations assigned by homology (TrEMBL; 98,705,220 entries) and by human curation (SwissProt; 556,196 entries). Assignment of functions to uncharacterized proteins is difficult because the sequence boundaries between functionally distinct groups of orthologs are difficult to determine. Therefore, many proteins have incorrect, uncertain, or unknown functions. The challenge is to devise robust approaches for assignment of in vitro activities and in vivo metabolic functions to uncharacterized proteins.
Multiple approaches have been used to assign functions to uncharacterized enzymes [1] [2] [3] [4] . Bioinformatic approaches, which are based only on sequence homology, are problematic 5 . Overannotation, for example, assignment of a function to homologs because they are members of a protein family, is a widely recognized problem in the automated annotation of proteomes encoded by sequenced genomes 6 . Analyses of sequence-function space in families is a valuable initial step even if uncharacterized homologs do not catalyze the same reaction using the same substrate, as they often catalyze mechanistically related reactions using substrates with conserved reactive groups (for example, abstraction of the α -proton of a carboxylate group in the enolase superfamily 7, 8 ). The conserved mechanistic features can provide important clues about the reactions catalyzed by homologs. However, identification of the substrate for and reaction catalyzed by the uncharacterized homologs requires additional information.
We are using a 'genomic enzymology' strategy 9, 10 to discover functions of microbial proteins and enzymes that constitute the majority of the UniProt database (67,155,056 bacterial, 2,310,947 archaeal, and 7,485,472 fungal proteins in release 2017_11). We use the ligand specificities of the SBPs of microbial transport systems to guide the discovery of catabolic pathways for the ligands; the ligand identifies the substrate for the pathway, as the genes that encode the transport systems and those that encode the pathways often are colocated. For this strategy we use sequence similarity networks (SSNs [10] [11] [12] ) of protein families to identify isofunctional (orthologous) families/clusters of SBPs and pathway enzymes and genome neighborhood networks (GNNs 10, 13 ) of the genes encoding these clusters to identify the pathways. We provide two communityaccessible 'genomic enzymology' web tools to enable broad use of this strategy: EFI-EST (http://efi.igb.illinois.edu/efi-est/) for generating SSNs 10, 12 and EFI-GNT (http://efi.igb.illinois.edu/efi-gnt/) for generating GNNs 10 . We discovered three SBPs for ABC transport systems (from Pfam family PF13407) that bind d-apiose. d-Apiose is a branched pentose (Fig. 1a) found in rhamnogalacturonan-II (RG-II) in the cell walls of higher plants and in apigalacturonan in the cell walls of aquatic monocots (for example, Zostera and Lemna 14 ; Fig. 1b ). d-Apiose increases cell wall stability by participating in interstrand RG-II crosslinking via boronate esters. The biosynthetic pathway for d-apiose is known [15] [16] [17] [18] ; UDP-d-apiose/UDPd-xylose synthase, which generates the branched structure, has been mechanistically characterized. Polysaccharide utilization loci (PULs) that degrade RG-II to monosaccharides have been identified in species of Bacteroides in the human gut microbiome 19, 20 (Supplementary Fig. 1 ): Bacteroides vulgatus and Bacteroides dorei utilize d-apiose, establishing the existence of uncharacterized d-apiose catabolic pathways.
The d-apiose-binding SBPs enabled discovery of a catabolic pathway involving a transketolase that converts d-apiose to intermediates in central carbon metabolism; this pathway is present in B. vulgatus and B. dorei. We also discovered three pathways that diverge from 3-oxo-isoapionate, a β -ketoacid, generated from Articles NATuRe ChemiCAL BiOLOGy d-apionate by a novel d-apionate oxidoisomerase: two pathways involve decarboxylases from different enzyme families, and the third involves a transcarboxylase/hydrolase that shares mechanistic features with RuBisCO. This study provides a compelling example of how SSNs and GNNs can be used to discover novel enzymes in new metabolic pathways.
Results
Strategy for functional annotation. Our functional assignment strategy is based on (1) identifying the ligand for a SBP of an ABC, TRAP, or TCT transport system (Fig. 1c) and (2) discovering the ligand's catabolic pathway by using SSNs (Fig. 1d) and GNNs (Fig. 1e) to locate the genome neighborhoods that encode the pathway enzymes (Fig. 1f) .
The number and varieties of pathways that can be discovered is determined by the sizes and diversities of the libraries of (1) genomic DNAs (gDNA) that encode SBPs and (2) small molecules to screen their ligand specificities. Our gDNA library (408 species) was assembled from the ATCC and DSMZ culture collections. Our ligand library (405 compounds) 21 includes all d-and l-tetroses, pentoses, and hexoses and their aldonic and aldaric acids; all dand l-hexuronic acids; and other commercially available aldoses, including d-apiose, ketoses and oligosaccharides. We previously used these libraries to discover catabolic pathways for tetritols 22 , hexitols 21 , and tetronic acids 23 . We identified d-apiose as the ligand for three ABC SBPs from Pfam family PF13407 (specific for carbohydrates; 53,665 sequences in UniProt release 2017_07). Using SSNs and GNNs, the SBPs leveraged Identification of SBPs for d-apiose. We chose 414 targets to sample sequence-function space in PF13407; the SSN filtered with an alignment score of 115 (~63% pairwise sequence identity) is shown in Supplementary Fig. 2 . We were able to clone the genes encoding 73% (303) of the targets and purify the SBPs encoded by 39% of the genes (117; highlighted in blue, magenta, or red in the SSN); these were subjected to ligand screening. The identities of the screened SBPs are provided in Supplementary Dataset 1.
Ligand hits (> 5 °C ligand-induced stabilization) were identified for 89 SBPs (highlighted in magenta or red), including three that bound d-apiose, d-ribose, and d-ribulose (highlighted in red; located in a single cluster; Supplementary Fig. 2 ): UniProt ID A6VKQ8 from Actinobacillus succinogenes ATCC 55618, B1G898 from Burkholderia graminis C4D1M, and Q2JZQ5 from Rhizobium etli CFN42; Supplementary Table 1) .
We determined that d-apiose is the physiological ligand for the SBPs. The SBP from R. etli CFN42 (UniProt ID Q2JZQ5) was cocrystallized with d-ribose and d-apiose (Supplementary Table 2) ; however, hydrogen bonding patterns were similar enough that neither could be inferred as the physiological ligand ( Supplementary  Fig. 3 ). We then disrupted the gene in Agrobacterium radiobacter K84 that encodes an SBP (UniProt ID B9JK76) sharing 92% sequence identity with Q2JZQ5; we also disrupted four proximal genes encoding putative pathway enzymes. For all mutants, growth using d-ribose and d-ribulose as a carbon source was unaffected; however, growth with d-apiose was reduced or abolished ( Supplementary Fig. 4 ). The wild-type phenotype was restored by complementation. Because all three SBPs are located in the same SSN cluster (> 63% pairwise sequence identity), we assumed that they and the other sequences in the cluster (total of 356) are functional orthologs.
A flowchart describing how SSNs and GNNs were used to leverage the use of these SBPs to discover the catabolic pathways for d-apiose is provided in Supplementary Fig. 5 . The pathways are shown in Figs. 2a, 3a, 4a and 5a; the pathway enzymes that were characterized are encoded by the genome neighborhoods shown in Figs. 2b, 3b, 4b, and 5b.
Two types of catabolic pathways. The single SSN cluster containing the d-apiose-binding SBPs (alignment score 115; > 63% pairwise sequence identity; Supplementary Fig. 6 ) was used to generate a GNN ( Supplementary Fig. 7a ) that identified several Pfamcurated enzyme families (spoke-nodes): two families of kinases, two families of dehydrogenases, the fucose isomerase family (aldose/ketose isomerase), two families of transketolase domains, and the RuBisCO superfamily. This complexity suggested multiple pathways, i.e., the SBPs in the SSN cluster, participate in more than one catabolic pathway.
Using an increased alignment score (130; ~72% sequence identity), two major SSN clusters were obtained ( Supplementary  Fig. 6c,d ). The GNN ( Supplementary Fig. 7b identified two genome neighborhoods associated with two types of catabolic pathways:
(1) Transketolase pathway: the blue SSN/GNN cluster identified three enzyme families: (a) aldose/ketose isomerase (PF02952 or PF01261), (b) bidomain kinase (PF00370-PF02782), and (c) heterodimeric transketolase (PF00456 and PF02779-PF02780). These participate in the pathway in Fig. 2a . (2) Oxidative pathways: the red SSN/GNN cluster identified three types of enzyme families: (a) two dehydrogenase families (one with a PF01408 domain and one with a PF16896 domain), (b) three kinase families (PF07005-PF17042, PF025733-PF02734, and PF00370-PF02782), and (c) RLPs from the RuBisCO superfamily (PF00016-PF02788). These participate in pathways initiated by oxidation of d-apiose (Fig. 4a) or oxidation of d-apionate (Figs. 3a and 5a) .
We subjected the proteins encoded by the genome neighborhoods in Figs. 2b, 3b, 4b, and 5b to in vitro enzymatic assays and in vivo genetic analyses (knockouts) so that the pathways could be established.
Transketolase pathway characterization. Proteins from
Pectobacterium atrosepticum SCRI 1043 and A. succinogenes ATCC 55618 (genome neighborhoods in Fig. 2b ) were assayed (a complete set of pathway enzymes could not be successfully purified from either organism). The aldose/ketose isomerase (Q6D5T7 from P. atrosepticum SCRI 1043; PF01261) catalyzes isomerization of d-apiose to d-apulose (Supplementary Fig. 8 ). The kinase (Q6D5T8 from P. atrosepticum SCRI 1043) catalyzes phosphorylation of d-apulose to form d-apulose-4-phosphate ( Supplementary  Fig. 8 ). Furthermore, the heterodimeric transketolase (A6VKQ3 and A6VKQ4 from A. succinogenes ATCC 55618) catalyzes transfer of the glycolaldehyde group from d-apulose-4-phosphate to Table 3) .
Pectobacterium carotovorum WPP14, which also utilizes d-apiose and contains the same genome neighborhood found in P. atrosepticum SCRI 1043, was used for in vivo studies because it has a faster doubling time. Mutant strains were generated in which the genes encoding the pathway enzymes were disrupted; the mutants were unable to utilize d-apiose. When complemented, they recovered wild-type growth ( Fig. 2d and Supplementary Fig. 10 ). Taken together, the in vitro enzymatic and in vivo phenotypic characterizations establish the pathway in Fig. 2a . Fig. 2b ). The study characterizing the PULs for RG-II degradation reported that B. vulgatus ATCC 8482 is able to utilize d-apiose. Although we were not able to purify the isomerase and kinase from B. vulgatis, we determined that its transketolase catalyzes the conversion of d-apulose-4-phosphate and glyceraldehyde 3-phosphate to dihydroxyacetone phosphate and d-xylulose-5-phosphate ( Fig. 2a ; Supplementary Fig. 9 ). We also observed d-apiose-dependent growth and d-apiose-dependent upregulation of transcripts for the isomerase, kinase, and transketolase ( Supplementary Fig. 13 ).
The conservation of the isomerases and the sequence similarities of the kinases encoded by B. vulgatis, P. carotovoum, P. atrosepticum, and A. succinogenes, together with our experimental data for B. vulgatus, provide persuasive evidence that B. vulgatis uses the pathway in Fig. 2a . The study characterizing the PULs for RG-II degradation 20 reported that (1) B. dorei DSM 17855 is also able to utilize d-apiose, but (2) fourteen other species of Bacteroides are not. Of these sixteen species, only B. vulgatus and B. dorei encode isomerase, kinase, and transketolase orthologs, thereby providing additional evidence for the pathway in Fig. 2a and its presence in human gut microbiota.
We could not purify a Clostridial transketolase; however, genes predicted to encode orthologs are colocated with those encoding kinases, as well as isomerases from the l-arabinose isomerase family (PF02610); for example, the genome neighborhood of B. hydrogenotrophica DSM 10507 in Fig. 2b . We propose that species of Clostridia in the human gut microbiome also use the pathway in species (UniProt release 2017_07; July 2017; a spreadsheet listing these species is included in Supplementary Dataset 2), including species from the human gut microbiome and soil microbiomes. Both communities are expected to have access to plant cell walls.
Dehydrogenases in oxidative pathways. We next characterized the oxidative pathways that are encoded by the genome neighborhoods in Figs. 3b, 4b , and 5b. The catabolism of d-apiose requires both of the dehydrogenases identified in the GNN for the SBPs (Fig. 4a) one with a PF01408 domain and one with a PF16896 domain; the catabolism of d-apionate requires only the dehydrogenase with a PF16896 domain (Figs. 3a and 5a) .
Both dehydrogenases from A. radiobacter K84 were assayed (genome neighborhood in Fig. 4b ). The dehydrogenase with a PF01408 domain (B9JK80) catalyzed oxidation of d-apiose to d-apionolactone using NAD + ( 1 H NMR spectrum in Supplementary Fig. 14 ; kinetic constants in Supplementary Table 4) .
Catabolism of d-apionolactone should require its hydrolysis to d-apionate (Fig. 4a) . The genome neighborhoods that encode d-apiose dehydrogenase include a 'hypothetical' protein (for example, Fig. 3b ). The 'hypothetical' protein from A. radiobacter K84 could not be purified, so we purified an ortholog from the same genome neighborhood in Ochrobactrum anthropi ATCC 49188 (A6X3G3), which hydrolyzed d-apionolactone to d-apionate ( 1 H NMR spectrum in Supplementary Fig. 14) . The d-apionolactonases are members of a family not yet curated by Pfam (Supplementary Fig. 15 ).
When d-apionate was incubated with NAD + and the second dehydrogenase with a domain from PF16896 (UniProt ID B9JK75), NADH was generated. d-Apionate was converted to "3-oxo-isoapionate" ( Fig. 4a ; a β -ketoacid) by oxidation of the 2-OH group and migration of a hydroxymethyl group ( 1 H NMR spectrum in Supplementary Fig. 16 ; kinetic constants in Supplementary Table 4) ; we designate this protein "d-apionate oxidoisomerase". The reaction is reminiscent of reductoisomerase reactions in branched-chain amino acid synthesis [24] [25] [26] . The migration of the hydroxymethyl group may be either concerted or stepwise via formation of formaldehyde and an enolate anion intermediate (Fig. 6a) .
d-Apionate oxidoisomerases are present in the catabolic pathways in Figs. 3a, 4a, and 5a (genome neighborhoods in Figs. 3b, 4b, and 5b). The following sections describe identification of the downstream enzymes in the pathways.
Downstream enzymes in oxidative pathways.
Because the GNNs for the d-apiose-binding SBPs do not identify the complete oxidative pathways (Figs. 3a, 4a , and 5a; Supplementary Fig. 7) , we used the SSN and GNN for d-apionate oxidoisomerase, (PF16896; 500 sequences in UniProt release 2017_07) to identify the remaining pathway enzymes. Using an alignment score of 85 (~50% pairwise sequence identity), the SSN contains two major clusters ( Supplementary Fig. 17 ), with the larger cluster including the characterized d-apionate oxidoisomerase from A. radiobacter K84 (Fig. 4b) . Small clusters also are present, including one containing proteins from Clostridia in the human gut microbiome. Although the d-apiose-binding SBPs are genome neighbors of only the largest oxidoisomerase cluster (red nodes in Supplementary Fig. 17c ), we hypothesized that the family is isofunctional.
Pathway with a decarboxylase from the xylose isomerase family. The blue SSN/GNN cluster (smaller, not proximal to d-apiose-binding SBPs; SSN in Supplementary Fig. 17d ; GNN in Supplementary  Fig. 18 ) identifies four enzyme families: a decarboxylase (PF01261), a bidomain kinase (PF02733-PF02734), and two isomerases (PF00121 (triose phosphate isomerase family) and PF02502 (LacAB_rpiB family)). (Members of PF13561 (adh_short_C2 family) Supplementary Table 7. are identified, but these are distal to the oxidoisomerases and functionally irrelevant.) We previously established that orthologs of the isomerases catalyze conversion of l-erythrulose-1-phosphate to d-erythrulose-4-phosphate and that of d-erythrulose-4-phosphate to d-erythrose-4-phosphate, respectively 22 . Decarboxylation is required to convert 3-oxo-isoapionate to d-erythrose-4-phosphate, the expected product of the pathway. Therefore, (1) l-erythrulose (or l-erythrulose-1-phosphate) is generated from 3-oxo-isoapionate (or 3-oxo-isoapionate-4-phosphate) and (2) the member of PF01261 is a β -ketoacid decarboxylase (SwissProt-curated enzymes catalyze reactions with enolate anion intermediates). The pathway with l-erythrulose is shown in Fig. 4a .
P. atrosepticum SCRI 1043 utilizes d-apionate ( Supplementary  Fig. 19 ). The decarboxylase (Q6D8V4), the kinase (Q6D8V6), and both isomerases (Q6D8V5 (TIM family) and Q6D8V9 (LacAB_rpiB) family) were assayed (genome neighborhood in Fig. 4b ). Q6D8V4 catalyzed decarboxylation of 3-oxo-isoapionate to l-erythrulose ( Fig. 3b and Supplementary Fig. 20 ), Q6D8V6 catalyzed phosphorylation of l-erythrulose to l-erythrulose-1-phosphate, and Q6D8V5 and Q6D8V9 catalyzed the expected isomerizations of l-erythrulose-1-phosphate to d-erythrulose-4-phosphate and of d-erythrulose-4-phosphate to d-erythrose-4-phosphate, respectively (Supplementary Fig. 21 ; kinetic constants in Supplementary Tables 4 and 5) . We designate the decarboxylase "3-oxo-isoapionate decarboxylase". P. carotovorum WPP14 containing the same genome neighborhood was used for in vivo studies. Mutant strains were generated that separately disrupted the gene for each enzyme, and these were unable to use d-apionate; complemented strains recovered wildtype growth (Fig. 3d and Supplementary Fig. 19 ). Taken together, the in vitro enzymatic and in vivo phenotypic characterizations confirm the pathway in Fig. 4a .
P. carotovorum also utilizes d-apiose via the transketolase pathway (genome neighborhood in Fig. 2a) ; however, it does not encode d-apiose dehydrogenase or d-apionolactone hydrolase, which would be required to convert d-apiose to d-apionate. Therefore, d-apiose and d-apionate are independent carbon sources.
A SSN was generated for PF01261 in which the 3-oxo-isoapionate decarboxylase clusters (genome proximal to PF16896) were identified ( Supplementary Fig. 22 ). From the number of proteins in these clusters, the pathway in Fig. 4a is encoded by 176 bacterial species (UniProt release 2017_07; a spreadsheet listing these species is included in Supplementary Dataset 2) , including species of Actinobacteria and Proteobacteria in the soil microbiome.
Two pathways involving RLPs. The GNN for the red PF16896 SSN cluster (larger, SBP proximal; SSN in Supplementary Fig. 17 ; GNN in Supplementary Fig. 18 ) identified a kinase (PF07005-PF17042) and RLPs from the RuBisCO superfamily (PF00016-PF02788). Two genome contexts were identified (Figs. 4a and 5b) , each having a kinase but with different RLPs (the former containing d-apiose dehydrogenase and the d-apionolactonase). Because reactions catalyzed by RuBisCO 27 and the two previously characterized RLPs 28-31 generate enolate anions from ketose-1-phosphate substrates, we predicted that the kinases phosphorylate 3-oxo-isoapionate to 3-oxo-isoapionate-4-phosphate, the substrate for the RLPs (pathways in Fig. 4a,b) .
The remaining enzymes in the pathways were identified using SSNs and GNNs for the RuBisCO superfamily (PF00016-PF02788). Filtered with an alignment score of 95 ( Supplementary Fig. 23a ), the SSN contains clusters for form I (red), II (green), and III (blue) RuBisCOs as well as RLPs (form IV RuBisCOs) 32, 33 . Members of two RLP clusters have been characterized: 2,3-diketo-5-methylthiod-ribulose-1-phosphate tautomerase 28, 29 (magenta) and 5-methylthio-d-ribulose-1-phosphate isomerase 30, 31 (cyan). The genome neighbors of the oxidoisomerase are located in a third RLP cluster (yellow nodes); when this cluster is filtered with an alignment score of 140, several clusters are generated. The majority of the oxidoisomerase neighbors are located in two clusters (SSN in Supplementary  Fig. 23b ; GNN in Supplementary Fig. 24 ).
Pathway with an RLP decarboxylase. The red RLP SSN/GNN cluster ( Supplementary Figs. 23 and 24 ) identified the same isomerase families in the pathway that includes 3-oxo-isoapionate decarboxylase (Fig. 4a) ; however, the GNN identified a different kinase (PF07005-PF17042). We predicted a pathway (Fig. 3a) in which 3-oxo-isoapionate is phosphorylated to 3-oxo-isoapionate-4-phosphate before decarboxylation; erythrulose-1-phosphate, the product of the RLP-catalyzed reaction, is converted to d-erythrose-4-phosphate by the isomerases.
Proteins from two genome neighborhoods of A. radiobacter K84 (Fig. 4b) were assayed. The first neighborhood encodes the oxidoisomerase (B9JK75), the kinase (B9JK74), and the RLP (B9JK73); the second neighborhood encodes the l-erythrulose-1-phosphate isomerase (B9JN20) and d-erythrulose-4-phosphate isomerase (B9JN19) in a gene cluster that also participates in erythritol catabolism 22 . The expected intermediates were identified ( 1 H NMR spectra in Fig. 4b and Supplementary Figs. 25, 26, and 27) ; the orthologous kinase from B. graminis C4D1M (B1G889) was used because the A. radiobacter kinase (B9JK74) was insoluble. We designated the RLP "3-oxo-isoapionate-4-phosphate decarboxylase".
Strains of A. radiobacter K84 were generated in which pathway genes were disrupted; these strains were unable to utilize d-apiose. The complemented strains recovered wild-type growth ( Fig. 4e and Supplementary Fig. 28 ). Taken together, the in vitro enzymatic and in vivo phenotypic characterizations confirm the pathway in Fig. 4a .
From the number of proteins in the SSN cluster for 3-oxo-isoapionate-4-phosphate decarboxylase, the pathway in Fig. 4a is encoded by 204 bacterial species (UniProt release 2017_07; a spreadsheet listing these species is included in Supplementary Dataset 2) , including species of Proteobacteria in the soil microbiome.
Pathway with an RLP transcarboxylase/hydrolase. The blue RLP SSN/GNN cluster ( Supplementary Fig. 24 ) identified d-apionate oxidoisomerase, as well as the same kinase family (PF07005-PF17042) identified by the red RLP cluster (members of PF13561 (adh_short_ C2) are identified that are genome distal and functionally irrelevant).
A gene cluster from Ralstonia eutropha N-1 (Fig. 5b ) encodes the RLP, d-apionate oxidoisomerase, and the kinase. The kinase and RLP were both insoluble when expressed, and therefore the kinase (B1G889) in the RLP decarboxylase pathway (Fig. 4a ) was used to generate 3-oxo-isopropionate-4-phosphate, and the orthologous RLP from Xanthobacter autotrophicus ATCC BAA-1158 (A7IJG7; Fig. 5b ) was used to convert 3-oxo-isoapionate-4-phosphate to 3-phosphoglycerate (3-PGA) and glycolate ( Fig. 5a; 1 H NMR spectrum in Fig. 5c and Supplementary Fig. 29) . The reaction is initiated by decarboxylation to generate a stabilized enediolate intermediate, with the sequestered CO 2 carboxylating the adjacent enediolate carbon atom. The resulting 3-ketose-1-phosphate intermediate is hydrolyzed, as in the authentic RuBisCOcatalyzed reaction, to generate 3-PGA and glycolate. In support of this mechanism (Fig. 6b), [1-1 3 C]3-PGA was generated using 3-oxo-isoapionate-4-phosphate prepared from dl-[1-
13 C]apiose. Additionally, when the reaction was performed with unlabeled 3-oxo-isoapionate-4-phosphate in the presence of [ 13 C]bicarbonate and carbonic anhydrase, no 13 C could be detected in the 3-PGA by 1 H NMR spectroscopy, consistent with intramolecular carboxylate group transfer (Supplementary Fig. 30 ). We designate this RLP "3-oxo-isoapionate-4-phosphate transcarboxylase/hydrolase". Disruption of the genes encoding the pathway in R. eutropha (Fig. 5b) resulted in strains that could not utilize d-apionate ( Fig. 5d and Supplementary Fig. 31 ).
The genome of R. eutropha also encodes (in a distal gene cluster) glycolate oxidase, which catalyzes the conversion of glycolate to glyoxylate, and glyoxylate carboligase, which catalyzes the conversion of two molecules of glyoxylate to glycerate and CO 2 . Disruption of the gene encoding the FAD-binding subunit of glycolate oxidase (G0EVT6) reduced the growth rate and yield of cells that had d-apionate as a carbon source ( Supplementary Fig. 31 ), consistent with retaining the ability to assimilate the 3-PGA product, but not the glycolate product, of the transcarboxylase/hydrolase. Taken together, the in vitro enzymatic and in vivo phenotypic characterizations confirm the pathway in Fig. 5a .
From the proteins in the SSN cluster for the 3-oxo-isopropionate-4-phosphate transcarboxylase/hydrolase, the pathway in Fig. 5a is encoded by 108 bacterial species (UniProt release 2017_07; a spreadsheet listing these species is included in Supplementary Dataset 2), including species in the soil microbiome.
Pathway involving 3-oxo-isoapionate and a transketolase.
The oxidoisomerase SSN contains a small cluster that has proteins from Clostridia from the human gut microbiome (orange cluster in Supplementary Fig. 18c ). The GNN ( Supplementary  Fig. 6 ) identifies (1) a heterodimeric transketolase (PF00456 and PF02779-PF02780) and (2) a dehydrogenase (PF00389-PF02826). The transketolase polypeptides are in the same Pfam families as the transketolases in the pathway in Fig. 2a ; however, they are not in the same clusters (circled in orange in Supplementary Fig. 12 ). Thus, this transketolase, dehydrogenase, and d-apionate oxidoisomerase are predicted to participate in another catabolic pathway for d-apionate (Supplementary Fig. 32a ).
The genome neighborhood selected for experimental characterization is shown in Supplementary Fig. 32b . We assayed the oxidoisomerase, the dehydrogenase, and the hydroxypyruvate reductase from B. hydrogenotrophica DSM 10507, which catalyze the reactions shown in Supplementary Fig. 32a . For the transketolase, d-glycerate is generated from 3-oxo-isoapioinate in the presence of d-glyceraldehyde-3-phosphate; however, we were unable to determine the identity of the second product. The kinetic constants are summarized in Supplementary Table 4 ; the 1 H NMR spectra showing the formation of d-glycerate by the transketolase are shown in Supplementary Fig. 33 . Growth of B. hydrogenotrophica with d-apionate and the genetics of the pathway were not investigated. Although not fully developed, the data provide evidence for this pathway in another species of the human gut microbiome.
Of the proteins in the SSN cluster for the orthologs of the d-apionate oxidoisomerase family (PF16896) that participate in this pathway, we estimate that the pathway in Supplementary Fig. 32a is encoded by 13 Clostridial species (UniProt release 2017_07; a spreadsheet listing these species is included in Supplementary Dataset 2).
Discussion
Without targeting any specific environmental niche, our largescale strategy enabled identification of pathways by which d-apiose (and/or d-apionate) is degraded by members of the human gut (species of Bacteroides and Clostridia) and soil (A. radiobacter, P. carotovorum/P. atrosepticum, and R. eutropha) microbiomes. The specificities of three SBPs were sufficient to discover four pathways in > 1,350 microbial species and identify eleven new enzymatic functions. The identities of the pathways were not biased by a focus on specific organisms or environmental niches. The phylogenetic distribution of orthologs-for example, d-apionate oxidoisomerases-enabled the discovery of multiple metabolic strategies, including two pathways involving previously uncharacterized families of RLPs (Figs. 4a and 5a) . The EFI-EST and EFI-GNT web tools then allowed identification of orthologous targets for functional characterization by providing facile access to conserved genome neighborhoods in different organisms.
The d-apionate oxidoisomerase catalyzes the previously unreported migration of a hydroxymethyl group (Figs. 2a and 6a) . The members of this family (500 sequences; Supplementary Fig. 17 ) contain a conserved C-terminal substrate-binding domain ((PF16896; 6-phosphogluconate dehydrogenase (decarboxylating)) and an N-terminal NAD(P)-binding domain from one of several Pfam families, including PF07991 (acetohydroxy acid isomeroreductase, NADPH-binding) and PF03446 (6-phosphogluconate dehydrogenase, NADP-binding). The family appears to be isofunctional; however, only a fraction of the members of this family are encoded by the same genome neighborhoods that encode members of the d-apiose-binding SBP clusters (compare SSNs in Supplementary  Figs. 6 and 17) .
We also discovered two novel functions for RLPs (Figs. 4a, 5a and 6b). The two previously characterized enzymes (2,3-diketo-5-methylthio-d-ribulose-1-phosphate tautomerase and 5-methylthio-d-ribulose-1-phosphate isomerase) are involved in pathways for methionine salvage; both catalyze enolization reactions. We identified 3-oxo-isoapionate-4-phosphate decarboxylase and 3-oxo-isoapionate-4-phosphate transcarboxylase/hydrolase in pathways for d-apionate catabolism. Both reactions catalyze decarboxylation of a β -ketoacid to generate a stabilized enediolate intermediate, the 'reverse' of the carboxylation reaction catalyzed by RuBisCO. The active site of the decarboxylase protonates the intermediate to generate l-erythrulose-1-phosphate; the active site of the transcarboxylase/hydrolase uses the sequestered CO 2 to carboxylate the enediolate and hydrolyze the resulting β -ketoacid to glycolate and 3-PGA, partial reactions that are shared with RuBisCO. We expect that the 'decarboxylase clade' of RLPs ( Supplementary  Fig. 23b ) includes uncharacterized enzyme families that catalyze other decarboxylation/carboxylation reactions involving stabilized enediolate intermediates; the functions of these clades may provide useful insights into the evolution of the carboxylation function and the ability of members of this superfamily to distinguish between O 2 and CO 2 (refs [34] [35] [36] ). From a biological perspective, our elucidation of these pathways provides evidence for the evolution of several diverse catabolic pathways for d-apiose, with multiple strategies for debranching d-apiose. Three pathways exploit the oxidoisomerization of d-apionate to generate β -ketoacids that undergo decarboxylation reactions (Figs. 3a,  4a , and 5a); two pathways, one characterized (Fig. 2a) and the other proposed ( Supplementary Fig. 32a ), use homologous but nonorthologous transketolases to accomplish 'debranching' . The independent evolution of multiple pathways is intriguing and worthy of study; Supplementary Dataset 2 provides lists of the organisms in which these pathways were discovered to facilitate these efforts.
No single strategy can be expected to be successful for prediction and subsequent experimental assignment of functions to uncharacterized proteins discovered in genome projects; for example, not all proteins are enzymes in metabolic pathways, and the genes that encode the components of metabolic pathways are not always genome proximal, so functional linkages that facilitate hypothesis generation and testing may not be readily apparent. However, we suggest that given the appropriate diversity and size of ligand and gDNA libraries, this strategy could be broadly useful for additional SBPs as well as transcriptional regulators.
To enable the general use of this approach, we provide the EFI-EST and EFI-GNT web tools to members of the experimental community who are not experts in bioinformatics.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0067-7.
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Statistics.
No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment.
Sequence similarity networks (SSNs) and genome neighborhood networks (SSNs). The EFI-EST (http://efi.igb.illinois.edu/efi-est/) 10, 12 and EFI-GNT (http:// efi.igb.illinois.edu/efi-gnt/) 10 web tools were used to generate SSNs and GNNs, respectively. SSNs for Pfam families were generated using Option B of EFI-EST; sequence-function space in the SSNs was analyzed with Cytoscape, a desktop platform for visualizing complex networks (http://www.cytoscape.org/), using node attributes from the UniProtKB and other databases to assist segregating the SSN into isofunctional clusters.
EFI-EST uses a local database with sequences and bioinformatic annotations downloaded from the UniProtKB database and other databases; the SSNs in this manuscript were generated using sequences in UniProt 2017_07 (5 July 2017) and InterPro 64 (6 July 2017). Sequences homologous to a usersupplied query are collecting using Option A of EFI-EST; Option A was used to identify the members of the "d-apionolactone hydrolase" family that has not been curated by Pfam. SSNs for Pfam families were generated using Option B of EFI-EST. The alignment scores used for filtering the SSNs are given in the figure legends.
The GNN for the clusters in an input SSN is generated with EFI-GNT. EFI-GNT generates a GNN cluster for each input SSN cluster, with the hub-node of each GNN cluster representing the proteins in the input SSN cluster and the spoke-nodes identifying the proteins encoded by the same genome neighborhoods as the proteins in the SSN cluster (within a ± N ORF window, where N is specified by the user; 10 by default); the spoke-nodes represent the Pfam families of the neighborhood proteins to assist functional predictions. The co-occurrence frequencies of the SSN cluster proteins and their genome neighbors, as well as the distances between their genes in ORFs, are provided; functionally related proteins (same metabolic pathway) should have large co-occurrence frequencies and short intergenic distances; unless specified, GNNs were generated with a > 20% queryneighbor co-occurrence frequency.
EFI-GNT uses a local database with genome sequences downloaded from the European Nucleic Acid (ENA) database; the GNNs in this manuscript were generated using ENA release 132 (6 July 2016). The neighborhood windows and co-occurrence frequencies used for collecting and displaying the Pfam neighbors are given in the figure legends. EFI-GNT also collects proteins that are not members of Pfam families (~15% of the proteins in the UniProt database are not assigned to a Pfam family); these are designated members of the "none" hub-nodes in the GNN; these have been deleted in the GNNs in the figures for clarity.
EFI-GNT also provides interactive diagrams of the genome neighborhoods for the bacterial, archaeal, and fungal proteins in each cluster in the input SSN; with these, proteins encoded by genome neighborhoods in experimentally accessible organisms (gDNA availability and genetic tractability) can be selected for in vitro assays (proteins from multiple species often are selected to ensure that at least one ortholog can be purified) and in vivo characterization (phenotypes associated with genetic knockouts and/or regulation of transcripts).
The SSNs and GNNs were visualized and analyzed using Cytoscape 3.3.0 with a MacPro computer with 128GB RAM.
Sequence-function space in PF13407. The SSN for PF13407 ( Supplementary Fig. 2 ) includes 603 clusters with > 10 members, so the 117 SBPs that could be purified and screened (nodes highlighted in blue, magenta, or red in Supplementary Fig. 2 ) provide access to only a small fraction of sequence-function space in PF13407. Its functional complexity cannot be represented adequately with a phylogenetic tree; SSNs provide an easy-to-compute and visualize alternative for surveying sequencefunction space in large protein families.
We also constructed a phylogenetic tree ( Supplementary Fig. 34 ) for representative sequences in the d-apiose-binding clusters in Supplementary Fig. 6 using the Neighbor-Joining method. The optimal tree with the sum of branch length = 5.4364709 was computed. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of number of amino acid substitutions per site. The analysis involved 61 amino acid sequences. All positions containing gaps and missing data were eliminated. The final data set contained a total of 298 positions. The analysis was performed using MEGA7.
Despite the enhanced accuracy of trees to distinguish orthologs from paralogues we use SSNs: both (1) the greater speed of generating SSNs (pairwise sequence comparisons) instead of trees (multiple sequence alignments) for large families and 2) the ability to construct GNNs for clusters in even very large SSNs and then interactively inspect individual genome neighborhoods for the members of each cluster establish the advantage of the synergistic generation and interpretation of SSNs and GNNs.
Reagents and analytical methods. Unless otherwise specified, all solvents and organic chemicals were purchased from Sigma-Aldrich and used without further purification. d-Apiose and dl- [1- 13 C]apiose were purchased from Omicron Biochemicals, Inc. Isopropyl-β -d-thiogalactoside (IPTG), ampicillin and kanamycin were purchased from Sigma-Aldrich. Primers were ordered from Integrated DNA Technologies. The nucleotide sequence was determined by ACGT. NMR spectra were recorded with Agilent 600 MHz NMR. Enzyme assays were performed with a UV-visible spectrophotometer (Varian CARY 300Bio). The consumption or formation of NADH was monitored as the decrease or increase in the absorbance at 340 nm using an extinction coefficient (ε) of 6,220 M Table 6 ) and inserted into the N-terminal TEV-cleavable 6 × -His-tag vector pNIC23-Bsa4, a pET23 based variant of the pNIC28-Bsa4 vector 37 by ligation independent cloning (LIC) 38 . The periplasmic signal sequence as predicted by the webserver SignalP 39 was not included in the final construct. All growth media contained 100 μ g mL −1 carbenicillin and 34 μ g mL −1 chloramphenicol. Escherichia coli BL21 (DE3) containing the pRIL plasmid (Stratagene) was transformed with the cloned target and used to inoculate a 20 mL culture of 2xYT. The overnight growth was used to inoculate 2 L of selenomethionine-containing ZYP-5052 (or methionine for native) autoinduction medium 40 in a LEX 48 airlift fermenter, and incubated for 4 h at 37 °C and then an additional 12-16 h at 25 °C. Purification of the solute-binding protein from the pelleted cell mass was done as previously described for the TRAP solute-binding proteins 41 with purification by metal-affinity and size-exclusion chromatography. The N-terminal TEV-cleavable 6 × -His-tag was not removed before DSF experimentation.
Expression and purification of pathway enzymes. Genes encoding enzyme targets were amplified by polymerase chain reaction (PCR) from respective genomic DNA using Phusion high-fidelity DNA polymerase (New England BioLabs) and the oligonucleotide primers listed in Supplementary Table 6 . The amplified genes were digested with appropriate restriction enzymes and ligated into similarly digested pET-28a, pET-15b, or pET23b (Novagen PET vectors) expression vectors for expression with an N-terminal or C-terminal His 6 -tag. For the two-subunit Clostridial transketolase, the genes for both subunits were inserted into a pET-28a vector to be expressed co-transcriptionally. C0CMQ5 was produced with an N-terminal His-tag; C0CMQ6 was produced without a His-tag. Identifying information for each protein and gene is given in Supplementary Table 7 .
The proteins were heterologously produced in E. coli strain BL21 (DE3). Cells transformed with the expression plasmids described above were grown at 37 °C in 2 L of Luria-Bertani broth (LB; supplemented with 50 μ g/mL kanamycin for pET-28a or 100 μ g/mL ampicillin for pET-15b or pET 23b) to OD 600 of 0.5 ~ 0.6, and expression of the genes was induced by addition of 0.5 mM isopropyl-β-d-thiogalactopyranoside (IPTG). The cultures were allowed to grow for an additional 12 h at 18 °C before the cells were harvested by centrifugation. The cells were resuspended in 80 mL of binding buffer (5 mM imidazole, 0.3 M NaCl, and 20 mM Tris-HCl, pH 7.9) and lysed by sonication (Fisher Scientific 550 Sonic Dismembrator). The lysate was cleared by centrifugation at 15,000 r.p.m. for 40 min at 4 °C. The clarified supernatant containing the His-tagged protein was applied to a column containing 10 mL of Ni-NTA resin (QIAGEN) previously equilibrated with binding buffer. After equilibration of the Ni-NTA resin with the clarified supernatant on a rocking platform for 30 min, the flowthrough was discarded. Then, the column was washed with 80 mL of wash buffer (25 mM imidazole, 0.3 M NaCl, and 20 mM Tris-HCl, pH 7.9) to elute weakly bound proteins. Resin-bound His-tagged protein was eluted with elution buffer-1 (250 mM imidazole, 0.3 M NaCl, and 20 mM Tris-HCl, pH 7.9) and collected in 4 mL fractions. The absorbance at 280 nm of each fraction was measured by a NanoDrop spectrophotometer; the purity of the fractions with strong absorbance at 280 nm (> 1 mg/mL) was checked by SDS-PAGE gel (mini-protean TGX precast gels from Bio-Rad). The purified fractions were pooled and dialyzed against 4 L of 20 mM Tris-HCl, pH 7.9 buffer three times (membrane tubing from Spectrum Laboratories). The recombinant proteins were concentrated, flash-frozen in liquid nitrogen, and stored at − 80 °C before use.
For the transketolase (A6VKQ3, A6VKQ4, and C0CMQ5/C0CMQ6), the lysate containing the His-tagged protein was loaded on a 5 mL HisTrap FF column (GE Healthcare) equilibrated with binding buffer. Then the protein was eluted with a linear 100 mL gradient from 0% to 100% of elution buffer 2 (1 M imidazole, 0.3 M NaCl, and 20 mM Tris-HCl, pH 7.9) and collected in 5 mL fractions.
Cloning and Protein Expression for Decarboxylase RLP (B9JK73, Q2JZQ0) and
Transcarboxylase RLP (A7IJG7). DNAs encoding B9JK73, Q2JZQ0 and A7IJG7 were inserted in frame into a T7-promoter-based pNYCOMPS23 vector using ligation-independent cloning 42 ; the RLP genes were fused to a leader sequence encoding a TEV-cleavable C-terminal His 10 tag. The inserted coding region of the corresponding RLPs was sequenced (GENEWIZ) completely to exclude the acquisition of unwanted coding changes during DNA amplification and cloning.
The resultant plasmids were transformed into E. coli C2527 (DE3) (New England Biolab), which contained an additional pRIL (StrataGen) for optimal protein expression 43 and used as pre-cultures grown at 37 °C overnight in 25 mL selenomethionine containing PSAM media 44 . For large-scale protein preparations, 2-L bacterial cultures were grown in PSAM-5052 auto-induction media 44 supplemented with 100 μ g/mL carbenicillin, 100 μ g/mL chloramphenicol and 1 mL/L antifoam 204 (Sigma) at 37 °C in LEX 48 airlift bioreactors (Epiphyte3, Canada). After 6 h of growth, the temperature of the cultures was increased to 42 °C, incubated for 30 min (heat-shock) to activate E. coli chaperon systems for optimal protein folding and then reduced to 22 °C for overnight incubation.
Cells were harvested by centrifugation at 6,500 × g and suspended in buffer containing 20 mM HEPES (pH 7.5), 500 mM NaCl, 20 mM imidazole, 0.1% IGEPAL, 20% sucrose, 1 mM β -mercaptoethanol (β ME). Cells were disrupted by sonication and cell debris was removed by centrifugation at 45,000 × g. The supernatants were applied to chromatography columns packed with 5 mL His60 superflow resin (Clontech) that had been equilibrated with buffer A (20 mM HEPES pH 7.5, 20 mM imidazole, 500 mM NaCl, 1 mM β ME). The columns were washed with buffer A, and the His 10 tagged RLPs were eluted with buffer B (20 mM HEPES pH 7.5, 350 mM NaCl, 250 mM imidazole, 1 mM β ME). The C-terminal His 10 tags from the proteins was removed by overnight digestion at 4 °C with the TEV protease at a 2,000:1 ratio of RLP:TEV. The tag-free proteins were then separated from the His 10 tag and TEV protease by a Superdex 200 (16/60) size exclusion chromatography column equilibrated with buffer containing 20 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol and 5 mM DTT. Potential peak fractions containing RLP proteins were assessed by SDS-PAGE, pooled and concentrated to 15-20 mg/mL using a 30 kDa Amicon Ultra-15 centrifugal filter device (Millipore).
Crystallization, data collection and structure determinations of solute-binding proteins. Prior to crystallization, recombinant TEV protease 45 was added at a ratio of 1 to 80 protein/TEV protease, and protein was buffer exchanged (into 20 mM HEPES pH 7.5, 5 mM DTT) and concentrated (to 40 mg mL Crystals were mounted on nylon loops, streaked through reservoir solution supplemented with glucose to 20% w/v and flash-cooled by plunging directly into liquid nitrogen. Data were collected at beamline 31-ID (LRL-CAT; Advanced Photon Source) using a wavelength of 0.9793 Å at 100 K and a Rayonix 225 HE detector. For the d-ribose complex, data were integrated and scaled in HKL3000 (ref. 46 ), initial phases were determined by selenomethionine SAD with HKL3000/SHELX 47 , an initial model was built using HKL3000/ ARPWARP 48 and the structure was refined with REFMAC. For the d-apiose complex data were integrated and scaled in MOSFLM, phases were determined using the d-ribose complex and the structure refined with PHENIX 49 . During the final refinement cycles, ligands were built into the observed difference density.
Data collection and refinement statistics are given in Supplementary Table 2 . There is a monomer per asymmetric unit with residues 26-312 fit to electron density (25-313 cloned). For both the d-ribose and d-apiose complex 99.7% of residues were in allowed regions of the Ramachandran plot.
Coordinates and structure factors have been deposited in the Protein Data Bank, and the accession codes are presented in Supplementary Table 2. nature research | life sciences reporting summary November 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided 
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
No animals were used
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
No human research participants were used.
